A share price of Healthequity Inc [HQY] is currently trading at $81.30, up 3.42%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The HQY shares have gain 1.75% over the last week, with a monthly amount drifted -0.81%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 4, April 2024, Benefits Leaders Believe in Power of AI, Considering Data Privacy and Accuracy. In a post published today on Yahoo Finance, New study indicates that benefits professionals are in an ‘early adopter’ stage with AI.
From an analyst’s perspective:
Healthequity Inc [NASDAQ: HQY] stock has seen the most recent analyst activity on April 04, 2024, when JMP Securities initiated its Mkt Outperform rating and assigned the stock a price target of $101. Previously, JP Morgan reaffirmed its Overweight rating on April 02, 2024, and elevated its price target to $108. On January 03, 2024, Barclays initiated with a Overweight rating and assigned a price target of $84 on the stock. Robert W. Baird upgraded its rating to a Outperform and increased its price target to $87 on September 21, 2023. Goldman upgraded its rating to a Neutral and raised its price target to $77 on October 21, 2022. KeyBanc Capital Markets started tracking with a Overweight rating for this stock on September 16, 2022, and assigned it a price target of $85. In a note dated July 12, 2022, Goldman initiated an Sell rating and provided a target price of $59 on this stock.
Healthequity Inc experienced fluctuations in its stock price throughout the past year between $48.86 and $84.49. Currently, Wall Street analysts expect the stock to reach $93.55 within the next 12 months. Healthequity Inc [NASDAQ: HQY] shares were valued at $81.30 at the most recent close of the market. An investor can expect a potential return of 15.07% based on the average HQY price forecast.
Analyzing the HQY fundamentals
Trailing Twelve Months sales for Healthequity Inc [NASDAQ:HQY] were 999.59M which represents 12.21% growth. Gross Profit Margin for this corporation currently stands at 0.6% with Operating Profit Margin at 0.12%, Pretax Profit Margin comes in at 0.08%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.03 and Total Capital is 0.04. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.43.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 78.75 points at the first support level, and at 76.19 for the second support level. However, for the 1st resistance point, the stock is sitting at 82.92, and for the 2nd resistance point, it is at 84.54.
Healthequity Inc [HQY] reported earnings per share of $0.63 for its fiscal quarter that ended on 1/30/2024. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.56/share, meaning a difference of $0.07 and a surprise factor of 12.50%. By comparison, the stated earnings for the previous quarter ended on 10/30/2023 were $0.6 per share as compared to estimates of $0.5 per share, a difference of $0.1 representing a surprise of 20.00%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Healthequity Inc [NASDAQ:HQY] is 4.76. As well, the Quick Ratio is 4.76, while the Cash Ratio is 3.45. Considering the valuation of this stock, the price to sales ratio is 7.01, the price to book ratio is 3.44 and price to earnings (TTM) ratio is 127.03.
Transactions by insiders
Recent insider trading involved Dilsaver Evelyn S, Director, that happened on Mar 26 ’24 when 32500.0 shares were sold. PRESIDENT AND CEO, Kessler Jon completed a deal on Mar 22 ’24 to sell 33765.0 shares. Meanwhile, EVP, GC & CORPORATE SECRETARY Ladd Delano sold 2558.0 shares on Mar 01 ’24.
